Contraception and ectopic pregnancy risk: a prospective observational analysis - 28/01/21
Doi : 10.1016/j.ajog.2020.10.013
Paige Schultheis, BA
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN
Melissa Natalie Montoya, MD
Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC
Qiuhong Zhao, MS, Johanna Archer, MD
Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN
Tessa Madden, MD, MPH
Department of Obstetrics & Gynecology, Washington University School of Medicine, St. Louis, MO
Jeffrey F. Peipert, MD, PhD 
Department of Obstetrics and Gynecology, Indiana University School of Medicine, 550 N University Blvd., UH2440, Indianapolis, IN 46208
Le texte complet de cet article est disponible en PDF.
Plan
| The Contraceptive CHOICE Project was funded by an anonymous donor. |
|
| J.F.P. has served as an advisory board member for Bayer and CooperSurgical and has received research support from Merck, Bayer, and CooperSurgical and Teva. T.M. serves as a data safety monitoring board member for phase 4 safety studies of Bayer contraceptive products. The remaining authors report no conflict of interest. |
|
| This work has been registered on ClinicalTrials.gov (NCT00635492). |
© 2020
Elsevier Inc. Tous droits réservés.
Vol 224 - N° 2
P. 228-229 - février 2021 Retour au numéro
Article précédent
- Perforation with Bakri balloon into broad ligament during management of postpartum hemorrhage
- Nicholas R. Spencer, Antonio Saad
- Myocardial injury associated with coronavirus disease 2019 in pregnancy
- Sarah L. Pachtman Shetty, Natalie Meirowitz, Matthew J. Blitz, Therese Gadomski, Catherine R. Weinberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?